Datum/Tijd
Date(s) - 25/04/2013
12:00
Categorieën Geen Categorieën
The public
workshop will be held on the afternoon of April 25 and all day, April
26, at the Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814,
Phone 301-897-9400.
Beginning at 1:00 pm on April 25, FDA will gather
patients’ perspectives on CFS and ME through a facilitated group
discussion focusing on two main topics:
- disease symptoms and daily
impacts that matter most to patients; and - patients’ perspectives on
current approaches to treating CFS and ME.
The second day will include a
scientific discussion with patients, clinicians, researchers and
government experts focusing on how to identify quantitative outcome
measures to determine if disease symptoms improve with specific drug
interventions. Additional information will be posted soon (see link
below), including the Federal Register Notice that will describe the
meeting format and provide details about how to register to attend the
meeting.